Home
»
Advances in Psychedelic Medicine
Advances in Psychedelic Medicine
Regular price
€78.99
602 verified reviews
100% verified
Delivery/Collection within 10-20 working days
Shipping & Delivery
Shipping & Delivery
Our Delivery Time Frames Explained
2-4 Working Days: Available in-stock
10-20 Working Days: On Backorder
Will Deliver When Available: On Pre-Order or Reprinting
We ship your order once all items have arrived at our warehouse and are processed. Need those 2-4 day shipping items sooner? Just place a separate order for them!
Close
Applications of Marijuana and Cannabidiol in Addictions Treatment
Bringing Psychedelics into Mainstream Pharma
Category=MKG
Category=MQP
Community-Based Harm Reduction Approaches to Caring for Psychedelic-Induced Psycho-Spiritual Crises
eq_isMigrated=1
eq_nobargain
Evidence for Clinical Applications of Ayahuasca
Product details
- ISBN 9781440864100
- Weight: 822g
- Dimensions: 156 x 235mm
- Publication Date: 22 Mar 2019
- Publisher: Bloomsbury Publishing Plc
- Publication City/Country: US
- Product Form: Hardback
Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems.
More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now moving into approved categories of medicine. The text is an up-to-date assessment of the latest advances in the field of psychedelic medicine, covering the use of LSD, psilocybin, MDMA, ayahuasca, and other substances to augment psychotherapies for a range of disorders. It discusses medical and psychiatric concerns, clinical efficacy and safety, ethical considerations, and neuroscience findings regarding the psychedelic compounds.
Topics covered include an overview of psychiatric applications of psychedelics; treatments for addictions and depressive disorders; effects of psychedelics on inflammation and neuroplasticity; evidence for clinical applications of DMT, ayahuasca, and cannabidiol; psychedelic treatment of sociopathic disorders; microdosing psychedelics; training psychedelic therapists; and community-based harm reduction approaches to managing psychedelic crises.
Michael Winkelman, PhD, is retired from the School of Human Evolution and Social Change at Arizona State University, where he served as director of the medical anthropology program.
Ben Sessa, MD, is a consultant child and adolescent psychiatrist working in adult addiction services and with PTSD in veterans.
Advances in Psychedelic Medicine
€78.99
